Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States Academic Article uri icon

Overview

MeSH Major

  • Chemotherapy, Adjuvant
  • Muscles
  • Neoadjuvant Therapy
  • Urinary Bladder Neoplasms

abstract

  • Most MedOncs (79%) in this survey offer perioperative chemotherapy to all patients with MIBC. This increased use of NACT is higher than previously reported, suggesting an increase in the adoption of recommendations that follow best evidence.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.urolonc.2013.12.012

PubMed ID

  • 24840869

Additional Document Info

start page

  • 637

end page

  • 44

volume

  • 32

number

  • 5